Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action against Roka Bioscience, Inc. and Lead Plaintiff Deadline of February 23, 2015

News provided by

Dec 26, 2014, 10:00 ET

NEW YORK, Dec. 26, 2014 /PRNewswire/ -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a securities class action has been filed in the United States District Court for the District of New Jersey on behalf of those who purchased shares of Roka Biosciences, Inc. ("Roka Bioscience" or the "Company") (NasdaqGM: ROKA), during the period between July 17, 2014 date of Roka Bioscience's initial public offering ("IPO") and November 6, 2014. (the "Class Period").

According to the lawsuit, Roka Bioscience's initial public offering documents failed to disclose known trends and uncertainties about the drastic decline in demand for its Atlas instruments that existed at the time of the IPO. On November 6, 2014, Roka announced a surprise loss of ($0.64) per share in the third quarter of 2014. Roka admitted that it had not placed any Atlas instruments in that quarter. On this news, shares of Roka fell $5.34, or more than 64%, on intraday trading to $3.00, on unusually heavy trading volume on November 7, 2014.

Plaintiff seeks to recover damages on behalf of all shareholders who purchased shares of Roka Bioscience during the Class Period described above.

No Class has yet been certified in the above action. If you wish to review a copy of the Complaint, to discuss this action, or have any questions, please contact Peretz Bronstein, Esq. or his Investor Relations Coordinator Eitan Kimelman of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email [email protected]. Those who inquire by e-mail are encouraged to include their mailing address and telephone number. If you suffered a loss in Roka Bioscience you have until February 23, 2015 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Eitan Kimelman 212-697-6484
[email protected]

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/shareholder-alert-bronstein-gewirtz--grossman-llc-reminds-investors-of-class-action-against-roka-bioscience-inc-and-lead-plaintiff-deadline-of-february-23-2015-300013992.html

SOURCE Bronstein, Gewirtz & Grossman, LLC